Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

NYSE:CBNA - New York Stock Exchange, Inc. - US15746L1008 - Common Stock - Currency: USD

22.43  -0.93 (-3.98%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CBNA. CBNA was compared to 404 industry peers in the Banks industry. CBNA has a bad profitability rating. Also its financial health evaluation is rather negative. CBNA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CBNA had positive earnings in the past year.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

CBNA has a Return On Assets of 1.35%. This is amongst the best in the industry. CBNA outperforms 86.14% of its industry peers.
CBNA has a Return On Equity of 19.98%. This is amongst the best in the industry. CBNA outperforms 97.52% of its industry peers.
Industry RankSector Rank
ROA 1.35%
ROE 19.98%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

CBNA has a Profit Margin of 39.56%. This is amongst the best in the industry. CBNA outperforms 95.54% of its industry peers.
CBNA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 39.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBNA has more shares outstanding
CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CBNA has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CBNA has a Debt to Equity ratio of 0.10. This is in the better half of the industry: CBNA outperforms 74.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC10.8%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 203.21% over the past year.
The Revenue has grown by 70.68% in the past year. This is a very strong growth!
EPS 1Y (TTM)203.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.33%
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-59.44%

3.2 Future

CBNA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.15% yearly.
CBNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.61% yearly.
EPS Next Y-46.03%
EPS Next 2Y-8.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.04%
Revenue Next 2Y16.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.38, which indicates a rather cheap valuation of CBNA.
CBNA's Price/Earnings ratio is rather cheap when compared to the industry. CBNA is cheaper than 95.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of CBNA to the average of the S&P500 Index (29.35), we can say CBNA is valued rather cheaply.
A Price/Forward Earnings ratio of 9.60 indicates a reasonable valuation of CBNA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBNA indicates a somewhat cheap valuation: CBNA is cheaper than 71.04% of the companies listed in the same industry.
CBNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 5.38
Fwd PE 9.6
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as CBNA's earnings are expected to decrease with -8.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (3/7/2025, 8:10:06 PM)

22.43

-0.93 (-3.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-28 2025-01-28/amc
Earnings (Next)N/A N/A
Inst Owners40.02%
Inst Owner ChangeN/A
Ins Owners18.65%
Ins Owner Change100%
Market Cap147.14M
Analysts82.22
Price Target30.94 (37.94%)
Short Float %1.2%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.06%
PT rev (3m)9.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)13.93%
EPS NY rev (3m)13.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)9.7%
Revenue NY rev (3m)20.83%
Valuation
Industry RankSector Rank
PE 5.38
Fwd PE 9.6
P/S 2.78
P/FCF N/A
P/OCF N/A
P/B 1.4
P/tB 1.4
EV/EBITDA N/A
EPS(TTM)4.17
EY18.59%
EPS(NY)2.34
Fwd EY10.41%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.07
BVpS15.98
TBVpS15.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 19.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 39.56%
GM N/A
FCFM N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)203.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.33%
EPS Next Y-46.03%
EPS Next 2Y-8.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-59.44%
Revenue Next Year6.04%
Revenue Next 2Y16.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A